Real Experts. Real Trades. Real Profits
One of the OGs of online trading and education, Jason Bond brings over a decade of experience teaching regular folks how to trade stocks. Unlike most “paper portfolio” instructors, Jason teaches students his favorite strategies and how he applies them in his real-money account.
Small Account Journey
Jason’s goal for Small account Journey is to grow a $2,000 account into $100,000 using high probability, defined risk trading strategies. Subscribers get weekly LIVE trading sessions, interactive Q&A, Alerts, and a comprehensive suite of training materials including an on-demand video library, Jason’s cheat sheet and more!
Jason’s goal for Jason Bond Picks is for subscribers to soak up as much knowledge and insight from his teachings as possible. Members will receive access to Jason’s educational library, DAILY emails with Jason’s trade plans, – PLUS alerts about Jason’s trades BEFORE he trades, and get direct access to his educational resources upon subscribing.
As tensions between the US and China continue to escalate, one stock has caught our attention - MP Materials (MP). The company's shares have surged over 20% in a single day, making it one of the biggest gainers on the market today. But what's behind this sudden...
In a major breakthrough, Verve Therapeutics (VERV) has announced positive results from its Heart-2 clinical trial. This news sent shockwaves through the market, with shares surging by over 21% today. So what does this mean for investors? And is Verve Therapeutics a...
The markets are always full of surprises, and today is no exception. Banco Macro (NYSE:BMA), an Argentine bank with operations in the region, has seen its stock price soar by a whopping 10.3% as investors react to recent news about Argentina's economic prospects....
In a move that has sent shockwaves through the biotechnology sector, the U.S. Food and Drug Administration (FDA) announced yesterday its plan to replace animal testing with "more effective, human-relevant methods," including artificial intelligence (AI) models in...
As I write this, NextNRG (NXXT) is on fire. No, not literally - although that would be a great headline for a different kind of article! But seriously, with its stock price up 8.95% today as of this writing and a whopping 161% year-over-year revenue growth in March...
In a move that's got investors buzzing, Keros Therapeutics (NASDAQ: KROS) has announced a review of strategic alternatives to maximize stockholder value. This news comes as of this writing, the company's shares have surged 14.42% today, making it one of the biggest...
The news is out, and the market is abuzz. President Trump has signed a series of executive orders aimed at expanding coal power in the US, citing its importance to the booming AI industry. As investors, we're left wondering what this means for one of America's...
As the global economy navigates through uncertain waters, one sector that's consistently shown resilience and growth potential is renewable energy – particularly solar power. And within this space, First Solar, Inc. (NASDAQ:FSLR) has emerged as a standout...
In a market where innovation and technology are driving growth, Cognyte Software (CGNT) is making waves with its cutting-edge investigative analytics solutions. The company's recent financial results have been nothing short of impressive, with double-digit revenue...
In a market where tech stocks are often associated with high growth and volatility, Progress Software (PRGS) has been flying under the radar. However, its recent earnings report has caught my attention, and I believe it's worth taking a closer look. Progress...